May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Yüksel Ürün: FDA approves neoadjuvant and adjuvant durvalumab in MIBC
Mar 30, 2025, 16:44

Yüksel Ürün: FDA approves neoadjuvant and adjuvant durvalumab in MIBC

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on X:

“Big win for bladder cancer care!

FDA approves neoadjuvant and adjuvant durvalumab (NIAGARA trial) in MIBC!

Chemo and immunotherapy before surgery. Immunotherapy after.

PFS and OS both improved.

Proud to be one of investigator of this milestone!”

Yüksel Ürün: FDA approves neoadjuvant and adjuvant durvalumab in MIBC

More posts featuring Yüksel Ürün.